Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAK6 . This antibody is tested and proven to work in the following applications:

Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAK6 . This antibody is tested and proven to work in the following applications:

Description: A Rabbit Polyclonal antibody against PAK6 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

Description: A Rabbit Polyclonal antibody against PAK6 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PAK6 (Center). This antibody is tested and proven to work in the following applications:

Description: Rabbit polyclonal PAK6 antibody

Description: Rabbit polyclonal PAK6 antibody

Description: Affinity purified Rabbit polyclonal PAK6 antibody

Description: Purified Polyclonal PAK6 antibody

Description: PAK6 Antibody: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6. These proteins are not activated by Cdc42/Rac binding. PAK6 was initially identified as an androgen receptor in a yeast two hybrid screen and was found to be highly expressed in testis and prostate tissues. Later experiments have shown it to be activated by MAP kinase kinase 6 and p38 MAP kinase, suggesting that PAK6 may play a role in the cellular response to stress-related signals.

Description: PAK6 Antibody: The p21-activated kinases (PAKs) are serine-threonine kinases that bind to the active forms of Cdc42 and Rac. They are divided into two groups, the first of which include PAK1, 2 and 3, and can be activated by Cdc42/Rac binding. Group 1 PAKs contain an autoinhibitory domain whose activity is regulated by Cdc42/Rac binding. The group 1 PAKs are known to be involved in cellular processes such as gene transcription, apoptosis, and cell morphology and motility. Much less is known about the second group, which includes PAK4, 5 and 6. These proteins are not activated by Cdc42/Rac binding. PAK6 was initially identified as an androgen receptor in a yeast two hybrid screen and was found to be highly expressed in testis and prostate tissues. Later experiments have shown it to be activated by MAP kinase kinase 6 and p38 MAP kinase, suggesting that PAK6 may play a role in the cellular response to stress-related signals.

Description: Rabbit polyclonal PAK6 antibody

Description: Rabbit polyclonal PAK6 antibody

Description: A polyclonal antibody against PAK6. Recognizes PAK6 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

Description: A polyclonal antibody against PAK6. Recognizes PAK6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

Description: A polyclonal antibody against PAK6. Recognizes PAK6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:100

Description: A polyclonal antibody against PAK6. Recognizes PAK6 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

Description: A polyclonal antibody against PAK7/PAK6. Recognizes PAK7/PAK6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/40000

Description: Antibody raised against PAK6

Description: This gene encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. These kinases function in a number of cellular processes, including cytoskeleton rearrangement, apoptosis, and the mitogen-activated protein (MAP) kinase signaling pathway. The protein encoded by this gene interacts with androgen receptor (AR) and translocates to the nucleus, where it is involved in transcriptional regulation. Changes in expression of this gene have been linked to prostate cancer. Alternative splicing results in multiple transcript variants.

Description: This gene encodes a member of a family of p21-stimulated serine/threonine protein kinases, which contain an amino-terminal Cdc42/Rac interactive binding (CRIB) domain and a carboxyl-terminal kinase domain. These kinases function in a number of cellular processes, including cytoskeleton rearrangement, apoptosis, and the mitogen-activated protein (MAP) kinase signaling pathway. The protein encoded by this gene interacts with androgen receptor (AR) and translocates to the nucleus, where it is involved in transcriptional regulation. Changes in expression of this gene have been linked to prostate cancer. Alternative splicing results in multiple transcript variants.

Description: Unconjugated Rabbit polyclonal to PAK6

Description: (IN) PAK6 peptide

Description: Mouse polyclonal to PAK6

Description: Rabbit polyclonal to PAK6

Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PAK6 antibody, catalog no. 70R-12193

Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PAK6 antibody, catalog no. 20R-1757

Description: A cloning plasmid for the PAK6 gene.

Description: Human PAK6 (GenBank Accession No. NM_020168), a.a. 385-680, MW=34.2 kDa, expressed in E. coli.